Skip to main content
. 2016 May 20;2016(5):CD009491. doi: 10.1002/14651858.CD009491.pub2

Bhalla 2006.

Methods Parallel‐group single‐centre randomized controlled trial conducted in India in 2000
Participants 252 adults undergoing diagnostic or therapeutic upper gastrointestinal endoscopy. Authors stated that there were no difference in baseline characteristics of the 3 groups
Interventions 1) Intravenous midazolam 5 mg (3 mg if older than 65)
2) Intravenous diazepam 5 mg (3 mg if older than 65)
 3) Intravenous saline (placebo)
Outcomes Measured during the procedure:
Vital signs (minimum oxygen saturation)
Vital signs (oxygen desaturation < 90%)
Vital signs (tachycardia defined as heart rate > 140 bpm)
Vital signs (bradycardia)
Vital signs (hypertension defined as systolic blood pressure > 200 mmHg)
Incomplete procedures
Difficulty performing procedure
Discomfort/pain
Notes Conflicts of interest or funding sources were not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Block randomisation"
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Endoscopist and investigator recording haemodynamic data were not aware of the nature of the medications
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Endoscopist and investigator recording haemodynamic data were not aware of the nature of the medications
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No loss to follow‐up reported
Selective reporting (reporting bias) Unclear risk No clear evidence that measured outcomes were not reported (trial protocols were not sought for confirmation)
Other bias Low risk None expected